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Abstract
A successful photodynamic therapy (PDT) requires a specific photosensitizer, oxygen
and light of a specific wavelength and power. Today photodynamic therapy (PDT) is
administered to patients with light-emitting diode (LED) panels. These panels deliver
a non-uniform light distribution on the human body parts, as the complex human
anatomy  is  not  a  flat  surface  (head  vertex,  hand,  shoulder,  etc.).  For  an  efficient
photodynamic therapy (PDT), a light-emitting fabric (LEF) was woven from plastic
optical fibers (POF) aiming at the treatment of dermatologic diseases such as actinic
keratosis (AK). Plastic optical fibers (POF) (Toray, PGR-FB250) have been woven in
textile in order to create macro-bendings, and thus emit out the injected light directly
to  the  skin.  The  light  intensity  and  light-emitting  homogeneity  of  the  LEF  were
improved thanks to Doehlert Experimental Design. During the treatment with PDT, the
photosensitizers were activated in the cancerous cells. These cells may be visualized, as
they show a characteristic fluorescence under UV light, which is called fluorescence
diagnosis (FD). Therefore, it  is proposed to modify the developed LEF for PDT to
measure the fluorescence amount. For this aim, a part of POFs was cut out to observe
the quantity of light that could be collected while the LEF was connected to a light
source. The first prototypes showed the possibility of the illumination with the same
LEF without losing the efficiency but also imaging the collected light.
Keywords: light emitting fabric (LEF), plastic optical fiber (POF), photodynamic ther-
apy (PDT), weaving, fluorescence diagnosis (FD)
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1. Introduction
The actinic keratosis (AK) is a pre-cancerous condition due to chronic UV light exposure that
may develop into non-melanoma skin cancer [1,  2].  Thus, the treatment of AK is highly
recommended. The AK lesions are characterized by red, scaly and crusty plaques or papules [3,
4]. This skin disease mainly affects fair-skinned individuals (face, bald head, forehead, etc.) [5].
There are many treatment options for AK. Cryosurgery, curettage and photodynamic therapy
(PDT) are the common treatments. Cryosurgery is an operation to destroy the tissue by using
freezing temperature performed with liquid nitrogen or carbon dioxide. This method is
efficient on the thinner lesions but less successful on the thick lesions and may result in
scarring [6]. Curettage is used to scrape of larger, hypertrophic lesions with a curette. The
drawbacks of this technique are the necessity for a local anesthesia and the scars [7].
Photodynamic therapy (PDT) is a noninvasive method, particularly used to treat pre-cancerous
or cancerous lesions with the combination of a photosensitizer and an appropriate light.
PDT has been increasingly used to treat AK, as it is efficient as other techniques given before
but also has excellent cosmetic results, repeatable and does not kill the healthy cells (selective
cell killing) [8, 9]. This treatment is also suitable for noncancerous lesions such as psoriatic,
acne vulgaris, pre-cancerous lesions as AK and Bowen, and cancerous lesions as basal cell
carcinoma (BCC) and squamous cell carcinoma (SCC) [9, 10].
The PDT leads to selective destruction of the cancerous cells by activated photosensibilisant
agent, methyl aminolevulinate (MAL) in Europe and 5-aminolevulinic acid (ALA) in USA. The
photosensitizers (PS) are activated with an appropriate light, which is red light (630 nm) in
Europe and blue light (450 nm) in USA in the presence of oxygen [11]. The activation of the PS
generates singlet oxygens (1O2) which causes chemical reactions inside the cancerous cells as
they are rich with molecular oxygen [12] (Figure 1). This is so-called “selective cells killing.”
Figure 1. Activation of PS.
In Europe, PDT is performed by using a drug photosensitizer methyl aminolevulinate (MAL
by Metvix, Galderma) on cancerous lesions and a 3-hour interval to start enlightenment [13].
The entire treated area is illuminated by a red light source (narrow spectrum around 630 nm)
[14]. The activation of Metvix required a dose of 37 J/cm2 [15, 16]. The light dose is determined
by such factors as the size of the light field, the distance between the lamp and the surface of
the skin, and the illumination duration. Therefore, it is not possible to treat numerous patients
per day since the treatment of a single patient takes about 5 hours. It is possible to reduce the
light exposition time by increasing the light dose, but the pain rate will also rise.
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Today PDT is administered by light-emitting diode (LED) panels (Figure 2) [17]. This is an
effective method without side effects with good cosmetic results. However, LEDs do not emit
the same light dose over the entire treatment area and do not adapt to the irregularities of the
body [13, 18]. Another disadvantage of this method is pain due to the dose of pure light that
effective treatment with LED panels [19, 20]. Indeed, if the light output was less, we could limit
the pain caused by the PDT.
Figure 2. LED panel light source (Aktilite CL 128, Galderma).
PDT needs to evolve despite its benefits, to make this treatment more effective and less painful.
The market innovates and proposes inventions that allow surmounting the inconveniences of
topical PDT with LED panels.
In order to maximize the comfort of the PDT and remove the disadvantages, Inserm (Institut
National de la Santé et de la Recherche Médicale, France) and ENSAIT (École Nationale
Supérieure des Arts et Industries Textiles, France) proposed replacing the LED panels by a LEF
composed of PMMA optical fibers (POF) [21–23].
2. Development and optimization of a LEF
Optical fibers carry the light between the distal ends but do not emit light laterally in their
natural state. There are three methods to bring out the light laterally. Mechanical process
consists of creating scratches on the surface of the POF (sandblasting or toothed roll) [24].
Chemical process is by applying a solvent which degrades the outside of the fiber and passes
light [25]. And finally the method of creating macro-bends (bindings in macroscopic size), to
not satisfy the total internal reflection to create a leakage [26–29].
The optical fiber used in the experiments consists of a Poly MethylMethAcrylate (PMMA) core
enveloped by a cladding made of fluorinated polymers. The core of the fiber has a refractive
index greater than the cladding’s, and therefore the light is confined thus completely reflected
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(Snell’s Law, Eq. 1). When a macro-bend is formed with an OF, light enters into the OF with an
angle larger than the critical angle (Eq. 2). and it undergoes multiple reflections.
(1)
1
critical cladding coreθ sin ( / )n n-= (2)
As a consequence, when the fiber is bent, the light rays outside of the bend section will be
emitted; the others will continue to meet internal reflection as seen in Figure 3 [30–32].
Figure 3. Multiple reflections in a bent optical fiber.
Weaving is a method of textile production which interlaces warp and weft yarns to form a
fabric (Figure 4).
Figure 4. Scheme of a plain weave.
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Thanks to the weaving technology, it is possible to create the macro-bends on the POFs as
observed on the cross sections of the fabric in Figure 5.
Figure 5. Bending loss in a POF inserted in a woven fabric.
It is possible to use different patterns to change the bending angles of the curvatures. There
are three types of fundamental weaving patterns: plain weave, twill weave and satin weave
(Figure 6) [33].
Figure 6. Fundamental Weaves: plain weave, twill 3-1, and satin 4, respectively.
Figure 6 shows the repeating pattern presentations of fundamental weaves. When the warp
yarn is on the top of the weft yarn, it is presented in black; in the other case it is white. A weft
float is designated as a number of warp yarns under the floating weft yarn between two
intersections.
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Figure 7. LEF connected to the light source.
The plain weave is the most basic of the three fundamental weaves. The weft thread passes
successively above and below the warp yarn, and this order is reversed for each weft line
(Figures 4 and 6).
The twill weave has a harness number equal to 1, and the crossing points form a diagonal
(Figure 6). It consists of floats longer than plain weave.
The crossing points of the satin weave are defined with the harness number, and it is higher
than 1 (Figure 6). Satin weave has longer floats compared to other fundamental weaves. This
is the reason that we have used this weave to produce our fabrics. Longer floats prevent
covering all the light-emitting POFs with warp yarns.
The quantity of the emitted light decreases with the distance to the light source as seen in
Figure 5. The light transmission loss in an optical fiber is defined as the following equation




é ù= ê úë û (3)
where α represents the light transmission loss (dB/km), the length of the optical fiber (km),
P(0) represents optical input power, and P(1) represents optical output power. Based on this
formula (Eq. 3), different weaving patterns were woven to measure their attenuation in the
same length.
The loss of the light in an OF depends on the radius of the bending curvature, the number of
bending points and the wavelength of the signal.
For a successful treatment, a special pattern (patent WO 2012098488 A2) composed of three
satin weaves was designed to obtain the same amount of bending, thus a homogenous light
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distribution on the whole length of the fabric when it is connected to sources from both ends
[36–38]. With this new pattern a homogenous light distribution was aimed for a successful
PDT. Moreover, the LEF is connected to the light source from the both distal ends.
Polyester Sinterama (330 dTex )was used as warp yarn with a density of 20 per cm. Optical
fiber PMMA Toray (250 μm) was used as a weft yarn with a yarn density of 37 per cm. The
size of the luminous fabric is 21.5 × 5 cm. The total length of POF is about 60 cm but only
21.5 cm of POFs are woven in the middle. The both ends of the LEF were connected to the
laser (1 W from both sides) as demonstrated in Figure 7 and the light intensity (mW.cm-2)
was measured for each cm2 of LEF length. For the medical application, it was important to
obtain the light intensity values change within the limits of -/+ 20%, for a homogenous light
distribution.
Figure 8. Scheme of the optimized weaving system.
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An LEF which diffuses homogeneously light was obtained by using the designed pattern.
However, it was also important to optimize the light intensity (mW.cm-2) for a successful PDT.
To improve the lateral light intensity and obtain an LEF that emits a consistent and powerful
light at the same time, tension is added on the warp yarns during weaving [39]. Thanks to the
added tension during weaving, it was possible to modify the curvatures of the optical fibers
inserted into the LEF.
It is also very important to maintain the low light from the connectors on both sides to avoid
feedback light toward the laser. This injection can increase the temperature of the laser sources,
which can cause damage to the devices.
Three warp beams were prepared for three different weaving zones A, B, C and the loads were
added on the beams, which were calculated with Doehlert experimental design. The samples
are woven with the weaving machine (Dornier, HTVS8-SD). The optimized weaving system
is shown diagrammatically below Figure 8.
In order to reduce the number of experiments, a three-factor Doehlert design was used in this
work. This experimental design allows to find out the best parameters to optimize the results.
The three weaving zones with different pattern combinations (A, B, C) were chosen as
variables, and the three levels are chosen 40, 70 and 100 g/warp yarn, respectively. Fifteen
samples were studied with the calculated tension parameters.
Furthermore, response surface methodology (RSM) graphics were generated with a Doehlert
matrix design results. The graphics showed the emplacement of best results for the light
intensity and light distribution homogeneity. Five more experiments were woven based on
these parameters which should give the compromise result with a good light intensity and less
heterogeneity (12.8 +/- 3 mW.cm-2.W-1). The sample number 15 gave the best result as predicted
and proved the reality of this approach (Figure 9). This was the optimal sample with given
pattern, warp/weft material and density.
Figure 9. Light distribution of the optimized with Doehlert Experimental Design.
This diffuser light textile meets the basic requirements for PDT: uniform distribution of light
and flexibility. The great light diffusers (500 cm2) textiles can be easily manufactured and can
be used not only on the skin but also in the peritoneal or pleural cavities.
PDT administrated with LEF will improve the effectiveness of treatment and make the
procedure almost painless. Clinical trials were started (at CHR and Klinikum Vest) on 55
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patients. For each patient, half of lesions were treated with conventional therapy, and the other
half with the smart textiles, to compare the pain and the effectiveness on the same patient. The
results are expected before 2017. Whenever the convincing results are provided, this method
will replace the current treatments with the LED panels.
In addition, the new procedure will allow to treating multiple patients simultaneously, with
less pain, under the supervision of doctors. Thanks to miniature laser sources and their
decreasing prices, this procedure may also be transformed into a portable medical device that
will allow patients to be active (Figure 10).
Figure 10. The PDT with woven LEF by ENSAIT (a), LEF inserted helmet design (b).
As the phototherapy has a good future, there are many concurrences developed to improve
the procedure existent. Philips has developed a new technology called “BlueControl” which
is a portable light therapy device for the treatment of Psoriasis Vulgaris. This device pro-
vides a treatment of 30 minutes per lesion, through the benefits of blue LED light without
UV (453 nm) [40, 41].
Philips also developed the “Bilirubin blanket,” made of woven fabric consisting of stitched
tiny blue LED lights. This device is used for the treatment of jaundice which is a condition
caused by high levels of bilirubin in the blood.
And Metvix Galderma has proposed PDT daylight as an alternative to the PDT conventional.
The daylight PDT allows patients to be active and under the sun during treatment, contrary
to illumination with a fixed wavelength in clinical place [42, 43]. Daylight PDT has a good
efficiency and is less painful thanks to low light output compared to the conventional method.
However, this new method has several disadvantages. Allowing the patient to prepare the area
to be treated may cause a lack of control of the light dose and time of exposure. In addition,
the patient is dependent on the season and weather conditions.
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In conclusion, PDT with flexible woven LEF by ENSAIT overcomes the obstacles of the other
alternatives. One of the most important advantages of this technology is the possibility of using
different wavelengths and dose of light by just changing the light source, thus allowing the
treatment of different diseases (red for AK, blue for Jaundice, etc.). Also the possibility of using
miniature lasers prevents the lack of control of the light dose or time exposure. That makes the
treatment applicable any time or anywhere without depending on the weather conditions.
3. Future prospects of monitoring the cancerous cells with an LEF
During the PDT, the accumulated MAL is converted into active Protoporphyrine IX (PpIX)
with the light exposure in cancerous cells. These PpIX are characterized by a red fluorescent
color when viewed with a Wood lamp which uses ultraviolet (UV) light to examine the skin
([13, 44–47]; Figure 11). It is therefore possible to monitor the amount of PpIX in tissues by
measuring the fluorescence before or during treatment. This procedure is called fluorescence
diagnosis (FD) [13, 45, 48].
Figure 11. Imaging of PpIX after illumination with Wood Lamp to monitor the cancerous cells.
The use of LEF already developed in our research as a tool for FD is also investigated in this
work. The aim was to use the same LEF for not only treating but also monitoring the cancerous
cells. For this purpose, first of all, 1 fiber out of every 20 fiber is cut out from the connector on
both edges as in Figure 12, and 1 W light is injected inside the both connectors. Secondly, the
collected light from the fibers cut out (shown with second power meter sensor in Figure 12,
and the light puissance of LEF were measured (shown with first power meter sensor in Figure
12).
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Figure 12. Measure method for monitoring application.
Furthermore, with the aim of finding the best ratio between the number of POF for the
treatment and for the monitoring, the measures were repeated on the same LEF by cutting out
1 of 10 POF, 1 of 5 POF and 1 of 2 POF for using as a monitor. The results are given below for
each experience.
As given in Figure 13, the collected information from the POFs cut out for the monitoring was
increased with the number of the monitoring POFs. In the same time, there was no significant
decrease of light power on the LEF, except for the last trial with one of two POFs. This could
be explained by the light transmission of the neighbor POFs. On this wise, the emitted light
from the neighbor POFs may penetrate inside the concerning fiber and keep stable the light
intensity of the LEF in a 1 cm2 area.
However, the monitoring sample with one of two POFs showed low light output from the LEF
surface and the monitoring fibers. It shows that the monitoring POFs which are not covered
with several bended fibers may not accumulate enough quantity of scattered light from the
neighbor POFs.
The results were obtained from an LEF woven with 37 POFs/cm. The best compromise was
using one of fivePOFs as monitoring fibers which showed a good light output from the
monitoring fibers without losing the lateral light emission power.
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Figure 13. Monitoring measure results.
4. Conclusion
An LEF has been developed and optimized to use in PDT, thanks to the weaving technology
and Doehlert experimental design. Furthermore, it is proposed to use the LEF to observe the
cancerous cells that are visualized as red fluorescent after illuminated with UV light. The
procedure requires a treatment with red light for a specific time period, and then diffuses a
UV light to measure the fluorescence quantity to observe if there are more cancerous cells. The
trials to prove the possibility of using a part of POFs as a monitoring tool were experienced
successfully and worked well.
This work has demonstrated the possibility of treating and then controlling the amount of
remaining tumor cells with the same LEF. There are similar examples in dentistry, such as
fluorescence signal detection with polymeric optical fiber. The next step will be a simulation
of the fluorescence diagnosis by injecting fluorescence light to the surface of LEF and meas-
uring the output from the monitor optical fibers.
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